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Benzene is an important pollutant with carcinogenic potential. The main sources of benzene
exposure include its unabated industrial use, gasoline vapors, emissions from engines and to-
bacco smoke. Environmental and occupational exposure of benzene has been associated with
serious health hazards. Analysis of benzene is therefore important for the monitoring of envi-
ronmental quality. The metabolites of benzene, especially S-phenyl mercapturic acid (S-PMA)
and trans, trans-muconic acid (t,t-MA) have been used as sensitive biomarkers of benzene ex-
posure. Estimation of un-metabolized benzene in urine has also been suggested as a more reli-
able indicator of its exposure. This review describes various chromatographic methods for the













Benzene is an important contaminant with carcinogenic
effects.1 The potential sources of benzene exposure in-
clude its industrial usage, gasoline vapors, engine exhaust
and tobacco smoke. Such a massive environmental or oc-
cupational exposure of benzene poses serious health ha-
zard to worldwide population. The biological control of
exposition to benzene is of great importance to prevent
its toxic and carcinogenic effects and it is therefore very
relevant to monitor environmental quality as well as
benzene exposure in individuals. Although part of ben-
zene is excreted intact from the body, a major portion of
benzene is converted into several metabolites including
S-phenyl mercapturic acid (S-PMA), trans, trans-mu-
conic acid (t,t-MA), phenol, catechol and hydroquinone
(Figure 1). The relative production of benzene metabo-
lites is directly proportional to its exposure level.2 Qu et
al.3 have discussed the applicability of these metabolites
as possible biomarkers of benzene exposure in human
population. S-PMA and t,t-MA have been recognized as
the most sensitive markers of low-level benzene expo-
sure. On the other hand, urinary excretion of un-metabo-
lized benzene has also been used for the evaluation of its
low-level environmental exposure.4 Numerous methods
have been developed to analyze benzene and its metabo-
lites to evaluate benzene exposure so that effective pre-
emptive measures could be timely imposed. The aim of
this short-review is to summarize various chromato-
graphic methods for the estimation of benzene and its




















Figure 1. Schematic presentation of metabolic pathways of ben-




A simple and reliable field method for the analysis of
benzene in exhaled air has been reported by Ljungkiust
and Norlinder.5 The sample was collected directly on ab-
sorbent tube using modified sampling device and de-
sorbed thermally for the analysis by gas chromatography
(GC). The advantages of this method were suggested to
be easy transportation, stability of samples (1 week), no
sample preparation or clean up and low detection limit
(0.5 g/m3).5 Recently, Yamada et al.6 have used passive
air samplers packed with activated charcoal to absorb
volatile organic compounds including benzene prior to
analysis by GC coupled with flame ionization detection
(GC-FID), with determination limit of 0.3 g/m3. A bat-
tery operated gas chromatography-mass spectrometry
(GC-MS)7 system has been devised for on-time monitor-
ing of benzene concentrations in air while driving or re-
fueling the vehicle, with a detection limit of 1 g/m3. Sa-
ba et al.8 collected benzene from air samples using ad-
sorbent cartridges with simultaneous adsorption of
pre-established amounts of D6-labelled internal standard.
Desorption of benzene was performed by solid-phase
microextraction (SPME) prior to analysis by GC-MS with
demonstrated linearity in the range of 10–400 ng of ben-
zene.8 Amagai and coworkers9 used GC-MS for deter-
mining benzene levels in indoor and outdoor air during
summer (indoor, 0.694–3.11 g/m3; outdoor, 0.779–3.17
g/m3) and winter (indoor, 1.65–6.89 g/m3; outdoor,
1.35–6.04 g/m3). Wester et al.10 determined benzene in
smokers’ (6.8 ± 3.0 ppb) and nonsmokers’ breath (2.5 ±
0.8 ppb) and smokers’ ambient air (3.3 ± 0.8 ppb) using
GC-MS. Gruenke and coworkers11 developed a sensitive
headspace gas chromatography (HS-GC) method coupled
with MS for the determination of benzene in air or breath
with the detection limits of 0.1 ppb/5 dm3 sample. The
same method can also be applied for the analysis of ben-
zene in blood samples with detection limit of 2 ng/cm3.11
Elke et al.12 reported an improved analytical method for
determination of benzene, toluene, ethyl benzene and
xylene (BTEX) in indoor air. The procedure consists of
passive air sampling using commercially available diffu-
sive samplers (charcoal pad), headspace SPME and high
resolution GC-FID. The lower detection limit using 2 h
sampling interval was in the range of 0.4–2 g/m3.
Tumbiolo et al.13 used a 30 min SPME sampling to de-
tect BTEX in ambient air as well as standard gas mix-
ture. The detection limit of this GC-MS procedure var-
ied between 0.05 and 0.1 g/m3 depending on the fiber
used for SPME.
Blood/urine
Estimation of un-metabolized benzene in blood or urine
is a useful index for the evaluation of benzene exposure
in humans. Although analysis of benzene in breath sam-
ples can be reliably carried out by GC-MS, the use of
HS-GC is more suitable for the determination of non-
-metabolized benzene in complex matrices like blood
and urine.14 Pekari et al.15 determined benzene in blood
using HS-GC equipped with a photoionization detector
with the detection limit of 5 nmol/dm3, being sensitive
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TABLE I. Chromatographic methods for the analysis of benzene in various matrices







































































enough for biological monitoring of benzene in exposed
workers. Alegretti et al.16 used SPME and HS-GC con-
nected to FID detector for simultaneous determination of
benzene, toluene and xylene in human blood samples. The
detection limit for benzene was found to be 1 g/cm3.
Kok and Ong17 described a sensitive HS-GC method for
the determination of benzene in blood and urine samples
using silicone gum capillary column and photoionization
detector. The recovery was more than 90 % and the de-
tection limits for blood and urinary benzene were 0.64
and 0.51 nmol/dm3 respectively.17 Lee and coworkers18
used headspace SPME for extraction of five thinner
components including benzene, toluene, butyl acetate,
1-butanol and isoamyl acetate from whole blood and
urine samples. A polydimethylsiloxane-coated SPME fi-
ber was exposed to the headspace of preheated (80 °C)
sample vial to allow the absorption of the compounds.
The fiber needle was then injected into a capillary GC
for quantitation. The recovery was 50–70 % and the de-
tection limit ranged 1.1–2.4 ng/0.5 cm3 sample.18 Perbel-
lini et al.19 determined BTEX in blood and urine sam-
ples using HS-GC coupled with MS detector; the limit
of detection was 16 ng/dm3.
Fiorentino and coworkers20 developed a method to
evaluate low concentrations of benzene in urine samples
by means of a dynamic headspace (50 cm3 of urine in a
120 cm3 vial). The urine was saturated with anhydrous
Na2SO4 in order to support the entrance of benzene in
the air over urine. The solvent was stripped from the
urine surface and concentrated on an adsorbent substrate
by means of a suction pump. Benzene was thermally de-
sorbed and injected into a GC column. The detection limit
of the method was 50 ng/dm3 with coefficient of varia-
tion to be 4.7 %. Ljungkvist et al.21 determined benzene
in urine using a procedure based on dynamic head-space,
analyte preconcentration on a solid sorbent, thermal de-
sorption and subsequent analysis by GC-MS. The lower
limit of detection was 6.5 ng/dm3 and the stability of
frozen samples was at least one month. Fustinoni et al.22
used SPME for sampling BTEX from the headspace of
urine followed by their selective analysis by GC-MS with
detection limits of 12–34 ng/dm3. They also observed
that BTEX remained stable for 2 months in frozen urine
samples. Skender and coworkers23 compared benzene
levels in the urine of smokers and nonsmokers using
HS-GC with the quantitation limit of 42 ng/dm3. Ljung-
kvist et al.24 determined benzene in urine of occupation-
ally or environmentally exposed persons using HS-GC
based on dynamic headspace, solid phase preconcentra-
tion, thermal desorption and flame ionization detection.
The limits of detection and quantitation were 7 ng/dm3
and 23 ng/dm3 respectively. The frozen samples were
stable for 1 year as compared to 1 week stability of re-
frigerated samples (4 °C).24 In a further development
Ljungkvist’s group25 trapped benzene on a solid adsor-
bent after passing through a membrane-based extraction
unit. The analyte was thermally desorbed and subjected
to GC-MS analysis. The lower limits of detection and de-
termination were found to be 12 ng/dm3 and 35 ng/dm3
respectively, suggesting the application of this procedure
for assessment of benzene exposure in occupationally
exposed subjects. Alkalde et al.26 used HS-SPME cou-
pled with GC-MS for rapid (< 10 min) analysis of ben-
zene in urine samples with a detection limit of 0.31 ppb
and the recovery of 99.3 %. Prado et al.27 evaluated the
effects of various factors to optimize urinary benzene de-
termination using SPME and GC-MS. The adequate con-
ditions were found to be: extraction temperature 15 °C,
incubation time 1 min, extraction time 1 min and 2.5 cm3
sample volume. The lower limit of detection was 0.043
ng/cm3. Another sensitive method (detection limit, 0.28–
0.5 ppb) based on HS-SPME coupled with GC-MS was
reported for simultaneous determination of benzene, to-
luene and xylene in 1 cm3 of urine sample.28 Whereas,
Waidyanatha et al.29 used only 0.5 cm3 sample volume
for the analysis of urinary benzene by HS-SPME and
GC-MS. The high sensitivity (detection limit, 0.016
g/dm3) of this method was able to determine urinary
benzene in control subjects with a mean level of 0.145
g/dm3 (range, 0.027–2.06 g/dm3).
Water
Barnung and Grahl-Nielsen30 applied purge and trap tech-
nique for the concentration of benzene from water sam-
ples. The benzene was purged from the water by helium,
trapped on an adsorbent (Tenax-GC), desorbed by rapid
heating and transferred directly to a fused silica GC col-
umn. Using this procedure the benzene concentration of
0.1 g/dm3 from 5 cm3 water samples can be determin-
ed. Rosell et al.31 optimized purge and trap GC-MS pro-
cedure for simultaneous determination of ng/dm3 to sub
g/dm3 levels of BTEX together with other organics in
groundwater. Przyjazny and Kokosa32 described analyti-
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TABLE II. Chromatographic methods for the analysis of S-PMA and
t,t-MA in urine samples

























cal characteristics of HS-GC for determination of BTEX
in water samples. Another rapid and reproducible method
has been described for the determination of BTEX using
solid-phase extraction followed by GC-FID.33 Hexane
pretreated water samples were applied to C18 SPE col-
umn and BTEX were extracted with dichloromethane.
These investigators reported > 90 % recovery of BTEX
from 200 cm3 of hexane-pretreated water samples using
C18 adsorbent cartridges prior to GC-FID analysis.
34 Re-
cently, Almeida and Boas35 determined BTEX in water
samples using SPME and GC-FID. The detection limit
for benzene was found to be 15 ng/cm3. Arambarri et
al.36 developed a simple and rapid HS-GC procedure for
simultaneous determination of BTEX and alkyl ethers in
water samples. The method was applied for the screen-
ing of contaminants in river water with the determina-
tion limit of benzene as 0.07 g/dm3.
Cigarette Smoke
A simple, direct, and quantitative method using isotope
dilution GC-MS was developed for the determination of
benzene in mainstream vapor phase cigarette smoke.37
Vapor phase samples were collected cryogenically in a
series of four traps following removal of the particulate
phase with a Cambridge filter pad, recovering 75–85 %
of the total amounts in the initial trap and less than 1 %
in the final trap.37 Brunnemann et al.38 trapped benzene
from cigarette smoke in methanol using three midget
impingers at –78 °C prior to analysis by GC-MS. Darrall
and coworkers39 determined BTEX and other volatile com-
pounds including styrene, isoprene and acrylonitrile in
mainstream smoke of 26 cigarette brands using GC-MS.
Cookware
HS-GC has also been used for the analysis of benzene in
recycled polyethylene terephthalate (PETE) beverage bot-
tles40 and in non-stick cookware.41 Jickells et al.42 used
HS-GC to study migration of benzene originated from
tert-butyl perbenzoate (which is often present in plastic
cookware) to cooked food. Samples of thermoset poly-
ester showed migration levels of 1.9 to 5.6 mg/kg in ol-
ive oil after extraction for 1 hour at 175 °C. Whereas mi-
gration levels into olive oil at the same temperature for
samples produced with non-aromatic initiator were less
than 0.1 mg/kg. Varner et al.43 analyzed benzene in poly-
propylene food-packaging materials and food-contact pa-
raffin waxes. The polymer was dissolved in hexadecane
at 150 °C whereas the wax was melted in an 80 °C oven.
A simple helium-sparging apparatus was used to remove
the volatile chemical, collected in methanol and analyz-
ed by HS-GC equipped with a 30 m fused silica open tu-
bular capillary column and a photoionization detector.
Average recoveries of benzene from polymer and paraf-
fin wax were 63 and 70 % with the quantitation limits of
17 and 2 ppb, respectively.43
Soil
A simultaneous detection of BTEX in soil has been per-
formed using GC-FID.44 BTEX-dosed or contaminated
soil (20 g) was mixed with anhydrous sodium sulfate
and extracted with methylene chloride using Soxhlet ap-
paratus. Two other methods of extraction based on shak-
ing and sonication were also reported. The extract was
concentrated and injected in GC where the detection
limit for BTEX was found to be 0.8 mg/dm3.44 Recently
multiple-headspace (MHS)-SPME coupled with GC-FID
has been applied for the determination of BTEX in soil
samples.45 The sampling was performed for 30 min at
30 °C while the number of MHS-SPME ranged 2 (for di-
lute solutions) and 4 (for more concentrated solutions) to
completely extract the analytes. The lower limit of de-
tection for benzene was 0.2 ng whereas the linear range
was 0.44–158 ng.
Miscellaneous (adhesives, fruits, gasoline, oil, milk,
tissue)
A purge-and-trap GC-MS procedure has been described
for the determination of benzene in adhesive with recov-
eries of 70–85 % and detection limit of 10 ppm.46 Gor-
na-Binkul et al.47 isolated BTEX from fruits and vegeta-
bles using solvent extraction followed by their determi-
nation by GC-MS. Pavlova and Ivanova48 developed
GC-FID method for determination of benzene in gaso-
line. Comparison of two capillary columns, PONA and
TCEP revealed that GC-FID with TCEP column had se-
veral advantages including simplicity of handling, high
precision and accurate measurement of benzene con-
tent.48 HS-GC coupled with MS detection was used for
the analysis of BTEX in olive oil samples (Pena 2004).49
No special sample pretreatment was necessary except the
use of 600 mm3 of ethyl acetate as a chemical modifier
per 10 cm3 of oil sample. The detection limit of this pro-
cedure ranged 3–9 ng/cm3. Estimation of benzene and
toluene in human milk was performed using the tech-
niques of purge-and-trap coupled with GC-MS.50 Bech-
told et al.51 performed the analysis of benzene in animal
tissue by HPLC. Benzene was extracted with ethyl ace-
tate and analyzed by reversed-phase HPLC using liquid
scintillation spectrometry and UV absorption for de-
tection.
Analysis of Metabolites
Khoschsorur and Petek52 reported a rapid and sensitive
method for determination of benzene metabolites phenol
and p-cresol in human urine samples. One microliter of
urine was acid hydrolyzed, saturated with NaCl and then
extracted with diethyl ether. The ether phase was evapo-
rated to dryness, reconstituted with CCl4 and analyzed by
GC-FID. The detection limit was 0.1 g/cm3. Einig et
al.53 used GC electron capture detection for the measu-
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rement of urinary S-PMA after precolumn derivetization
and HPLC cleanup. The detection limit of this sensitive
method was found to be 60 ng/dm3. Waidyanatha et al.54
developed a GC-MS procedure for determination of uri-
nary t,t-MA and S-PMA with detection limits of 10
g/dm3 and 2 g/dm3, respectively. A capillary electro-
chromatography (EC) method for separation, detection and
determination of t,t-MA in urine has been used.55 The
sample was filtered through 0.22 micron membrane and
injected in a capillary (75 m i.d. and 80 cm length). The
analysis was conducted using the electrolyte consisted of
0.1 mmol dm–3 cetyltrimethyl ammonuim bromide in 60
mmol dm–3 phosphate buffer (pH = 7), constant voltage
of 30 kV and UV detection at 262 nm. The sensitivity
was 25 g/dm3 and the percent recovery was 100  8 %.
The urinary S-PMA in mouse was analyzed by HPLC
using ODS column, tetrabutylammonium hydrogen sul-
fate-methanol (75:25, v/v) as mobile phase and the ab-
sorbing wavelength at 255 nm for detection.56 The urine
sample was first preconcentrated on anion exchange re-
sin, extracted with diethyl ether and evaporated to dry-
ness, then dissolved in aqueous phosphoric acid and in-
jected into HPLC system. The detection limit of this
method was found to be 3 mg/dm–3 in mouse urine. Lee
et al.57 reported a sensitive HPLC method with fluores-
cence detection for simultaneous determination of hydro-
quinone, catechol and phenol in urine samples. After acid
hydrolysis the urine samples were saturated with sodium
sulfate on C18 column with gradient elution using two
mobile phases, 10 mmol dm–3 sodium acetate containing
0.5 % (v/v) acetic acid, with and without 20 % (v/v) aceto-
nitrile. In another method for quantitative measurement
of t,t-MA, catechol, hydroquinone and phenol in urine,
the hydrolyzed mixture of benzene metabolites was purified
and separated by solid-phase extraction with an anion ex-
changer followed by extraction with diethyl ether.58 The
clean-up procedure reduced the natural background from
mouse urine so that the detection limit of the metabolites
was in the range of 3–60 mg/dm3. Buratti et al.59 used
solid-phase ion exchange chromatography for sample
clean-up and HPLC for the analysis of t,t-MA, using re-
versed-phase C18 column, UV detection at 263 nm and
a mobile phase consisted of formic acid-tetrahydrofuran-
-water (14:17:969). The recovery of t,t-MA from urine
samples was > 95 % in 50–500 g/dm3 range. Maestri
and coworkers60 determined urinary t,t-MA by HPLC with
UV detection at 259 nm. The detection limit and recovery
were 3 g/dm3 and 90 % respectively. Tharnpoophasiam
et al.61 simultaneously analyzed urinary t,t-MA and S-
PMA by liquid extraction with ethyl acetate followed by
reversed-phase HPLC on Hypersil-ODS column using
gradient mobile phase of methanol and perchloric acid
and diode array detection at 205 nm (S-PMA) and 264
nm (t,t-MA). The recoveries of both the metabolites
were > 97 %. Marrubini et al.62 reported a coupled
column liquid chromatography for the estimation of
t,t-MA in human urine. The first column was packed
with Microspher C18 and the second column with
Hypersil-ODS. t,t-MA was detected by UV detection at
264 nm with the detection limit of 0.05 mg/dm3.
Melikian et al.63 developed a sensitive and specific
liquid chromatography-tandem mass spectrometry (LC/
MS/MS) assay for quantitation of benzene metabolites
t,t-MA, S-PMA, hydroquinone and catechol in urine
specimens. The efficiency of this assay was evaluated in
human urine specimens from smokers and nonsmokers
serving as benzene-exposed and nonexposed groups re-
spectively. Barbieri et al.64 also used LC/MS/MS for de-
termination of t,t-MA and S-PMA in urine samples after
SPME based purification. The limit of detection was
found to be 6 g/dm3 for t,t-MA and 0.3 g/dm3 for
S-PMA. Recently, a simple and rapid method using re-
versed-phase LC/MS/MS has been reported for simulta-
neous determination of urinary metabolites of benzene,
toluene, xylene and styrene.65 t,t-MA, hippuric acid, o-,
m- and p-methyl hippuric acid and phenylglyoxalic acid
were separated on reversed-phase LC C-18 column (1
mm i.d.). Average recoveries of these metabolites from
100 mm3 urine sample were 88–110 % and the quantifi-
cation limits were less than 30 ng/cm3 for each analyte
(3 ng/cm3 for t,t-MA).
CONCLUSION
Chromatographic methods are efficiently used for the
analysis of benzene and its metabolites in a wide variety
of matrices. The limits of detection associated with these
methods are quite diverse due to variations in the effi-
ciency of extraction/preconcentration techniques, recov-
ery from chromatography columns, and the sensitivity of
the detectors used. Most of the recent studies applied
SPME and HS-GC for the estimation of benzene. SPME
presents extraordinary advantages over traditional ex-
traction methods, because it integrates sampling, extrac-
tion, concentration and introduction of sample in a sin-
gle stage, which significantly minimizes the use of sol-
vents.66–68 Moreover, the requirement of small amount
of sample for SPME renders the technique highly suit-
able for the analysis of benzene in biological fluids.66
On the other hand, headspace sampling provides the ad-
vantage of protecting fiber from any damages (interfer-
ences) caused by high molecular weight substances and
other non-volatile contaminants present in sample ma-
trix.68 Thus, the advents of SPME and HS have greatly
reduced the complications associated with sample ex-
traction and matrix effects. For chromatographic separa-
tions, GC appears to be a method of choice for the anal-
ysis of benzene, whereas HPLC is commonly applied for
the estimation of benzene metabolites.
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SA@ETAK
Kratki pregled kromatografskih metoda za analizu benzena i njegovih metabolita
Haseeb Ahmad Khan
Benzen je zna~ajno zaga|ivalo s mogu}im kancerogenim djelovanjem. Glavni izvori izlo`enosti benzenu
su njegova nesmanjena industrijska uporaba, benzinske pare, ispu{tanje iz motora i duhanski dim. Izlo`enost
benzenu u okoli{u i na radnom mjestu predstavlja ozbiljnu opasnost za zdravlje. Stoga je ispitivanje benzena
nu`no za pra}enje kakvo}e okoli{a. Metaboliti benzena, posebice S-fenilmerkapturna kiselina (S-PMA) i trans,
trans-mukonska kiselina (t,t-MA) rabe se kao osjetljivi biomarkeri izlo`enosti benzenu. Utvr|ivanje nemetaboli-
ziranoga benzena u urinu tako|er predstavlja pouzdani pokazatelj izlo`enosti benzenu. U ~lanku su opisane kro-
matografske metode za utvr|ivanje benzena i njegovih metabolita u razli~itim okoli{nim i biolo{kim uzorcima.
ANALYSIS OF BENZENE AND ITS METABOLITES 175
Croat. Chem. Acta 79 (2) 169–175 (2006)
